Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

73
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
73
Narcolepsy01:07

Narcolepsy

100
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
100
Panic Disorder01:27

Panic Disorder

66
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
66
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

175
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
175
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

159
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
159
Bipolar Disorder01:30

Bipolar Disorder

63
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
63

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Replicable subcortical alterations linked to neurological soft signs in schizophrenia spectrum disorders.

Psychological medicine·2026
Same author

Shared and Distinct Time-Space Experiences Along the Psychotic-Affective Continuum.

Schizophrenia bulletin·2026
Same author

Resting-State Brain Age Predicts Cognitive and Sensorimotor Deficits in Schizophrenia Spectrum Disorders: A Validation & Longitudinal Study.

Research square·2026
Same author

Inter-Relationships Between Depressive Symptoms And Sleep Problems Among Older Adults With Depression: Findings of a National Survey in the USA.

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists·2026
Same author

Gender Differences in the Prevalence and Correlates of Post-Stroke Depression Among Older Stroke Survivors: Findings From a National Survey in China.

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists·2026
Same author

Inter-Relationships Between Depressive Symptoms and Cognition Among Older Adults in India: A Network Analysis of a Nationally Representative Sample.

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists·2026

Related Experiment Video

Updated: Jun 20, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.7K

Catatonia.

Dusan Hirjak1,2, Jonathan P Rogers3, Robert Christian Wolf4

  • 1Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. dusan.hirjak@zi-mannheim.de.

Nature Reviews. Disease Primers
|July 18, 2024
PubMed
Summary

Early recognition and treatment of catatonia, a neuropsychiatric disorder, are crucial. Prompt intervention using therapies like benzodiazepines can prevent severe complications and improve patient outcomes.

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.3K
Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
07:38

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Published on: May 27, 2021

7.8K

Related Experiment Videos

Last Updated: Jun 20, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.7K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.3K
Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
07:38

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Published on: May 27, 2021

7.8K

Area of Science:

  • Neuropsychiatry
  • Psychiatric Diagnostics

Background:

  • Catatonia is a neuropsychiatric disorder with motor, affective, and cognitive-behavioural signs.
  • Recognized as an independent diagnosis in ICD-11 since 2022, catatonia affects 5-18% of psychiatric inpatients and 3.3% of medical inpatients.
  • Unrecognized catatonia poses a risk for life-threatening complications.

Purpose of the Study:

  • Highlight the importance of early catatonia symptom recognition.
  • Emphasize the need for timely and appropriate treatment to ensure favorable outcomes.
  • Discuss current and potential therapeutic strategies for catatonia.

Main Methods:

  • Review of current literature on catatonia diagnosis and treatment.
  • Analysis of epidemiological data regarding catatonia prevalence.
  • Discussion of pharmacological and non-pharmacological treatment options.

Main Results:

  • Early identification of catatonia is critical for effective management.
  • Established treatments include benzodiazepines, electroconvulsive therapy, and NMDA antagonists.
  • Second-generation antipsychotics like clozapine and aripiprazole show efficacy in specific populations.

Conclusions:

  • Early and appropriate treatment, alongside screening assessments, can significantly reduce catatonia's high morbidity and mortality.
  • Improved recognition and management are essential in both psychiatric and non-psychiatric settings.
  • Further research into screening and treatment may enhance patient outcomes.